CNO Financial Group, Inc. (CNO)
Quantitative Summary
DeterministicCNO trades at 17.4x earnings, roughly in line with its sector average of 19.2x. Financial health is average: Piotroski 5/9, Altman Z 0.3.
Generated deterministically from quant metrics and financial statements. Not a recommendation.
Algorithmic Teardown
AI-GeneratedThe fundamental economics of CNO Financial Group reveal a capital structure under significant strain, characterized by an ROIC-WACC spread of -5.9%, indicating that the firm is currently destroying value relative to its cost of equity. Despite this negative economic moat, reported earnings per share are buoyed primarily by extreme financial leverage rather than operational efficiency; the DuPont decomposition shows an Equity Multiplier of 14.70x driving a modest ROE of 8.7%, while net margins remain thin at 5.1% and asset turnover is low at 0.12x. This reliance on debt amplifies solvency risks, as evidenced by a distressively low Altman Z-Score of 0.3, which flags potential bankruptcy territory, even though the Piotroski F-Score of 5/9 suggests moderate financial strength in terms of profitability and leverage trends over time.
Valuation metrics present a mixed picture where current multiples appear compressed relative to historical norms but remain elevated compared to sector peers on an absolute basis if growth expectations are low. The stock trades at a P/E ratio of 17.4x, sitting below the sector average of 18.9x, yet this discount may reflect market skepticism regarding future cash flow generation given the stagnant revenue growth of just 0.9% year-over-year and the widening gap between returns generated and capital costs. Without evidence of margin expansion or improved asset utilization to offset the high leverage, the current multiple implies a pricing environment that assumes limited upside potential until operational efficiency improves significantly.
Risk factors are heavily weighted toward solvency concerns rather than growth prospects, underscored by the critical Altman Z-Score and substantial insider activity showing $10,199,724 in net selling over the last 90 days. These signals suggest that management and major shareholders may be concerned about liquidity pressures or valuation levels amidst a fragile balance sheet. The combination of negative spread economics, high leverage-driven returns, and active insider divestment creates an asymmetric risk profile where downside protection relies on operational turnaround rather than multiple expansion or revenue acceleration.
Generated by LLM from quantitative data inputs. May contain inaccuracies. Not investment advice.
Valuation Context
Price Chart with Moving Averages
Quant Health Deep Dive
Profitability & Value Creation
DuPont Analysis — ROE Decomposition
Breaking down Return on Equity to see how the company generates its ROE — efficiency, margins, or leverage.
Balance Sheet Health
Insider Activity (Last 90 Days)
Open-market buys vs sells by company insiders. Source: yfinance.
Earnings Surprise History
EPS estimates vs actuals for the most recent reported quarters. Source: yfinance.
Underwater (Drawdown from Peak)
How far below the all-time high the price has been over time. Deeper = more pain for holders.
Rolling 60-Day Beta vs S&P 500 (VOO)
How the stock's sensitivity to market moves changes over time. β > 1 = more volatile than the market.
Fundamentals
Passive Flow Attribution
ETF Draft EffectWhen investors buy or sell ETFs like KIE or MDYV, the fund manager is mechanically forced to buy or sell CNO shares regardless of CNO Financial Group, Inc.'s individual fundamentals. We estimate $190M of passive capital is structurally linked to CNO through 8 tracked ETFs. Passive flows have a limited but growing influence on CNO's daily trading dynamics.
Passive exposure = Σ (ETF AUM × stock weight in ETF) across 8 tracked ETFs. Actual passive ownership is larger (includes mutual funds). Not investment advice.
ETF Contagion Visualizer
Simulate a price drop in CNO Financial Group, Inc. to visualize passive redemption contagion across ETFs and collateral stocks.
If CNO Financial Group, Inc. (CNO) experiences a significant drawdown, ETF redemptions can create collateral selling pressure on co-held stocks. Our model identifies UNUM GROUP (UNM) as the most exposed collateral stock, sharing 3 ETFs with CNO. This is the "Passive Contagion" effect described in the Inelastic Market Hypothesis.
Contagion model based on shared ETF exposure and constituent weights across 11 tracked ETFs. Estimated selling pressure is a simplified model — actual impact depends on market liquidity, ETF redemption mechanics, and market-maker activity.
CNO Ownership Dynamics
ETFs with Highest CNO Exposure
Float lock-up computed from 11 ETFs tracked by SecuritiesDB. Actual passive ownership is higher (includes mutual funds, pension funds, etc.).
Fails-to-Deliver (FTD) History
SEC-reported settlement failures. Elevated FTDs can indicate high short-selling pressure, operational settlement issues, or naked shorting activity.
| Date | Failed Shares | Close Price | Notional Value |
|---|---|---|---|
| 2026-05-06 | 49 | $45.52 | $2,230.48 |
| 2026-04-22 | 1,077 | $43.61 | $46,967.97 |
| 2026-04-08 | 2,160 | $41.70 | $90,072 |
| 2026-03-25 | 10,269 | $40.63 | $417,229.47 |
| 2026-03-06 | 74 | $42.15 | $3,119.1 |
| 2026-03-05 | 74 | $42.58 | $3,150.92 |
| 2026-02-18 | 38 | $43.12 | $1,638.56 |
| 2026-02-04 | 2 | $42.31 | $84.62 |
| 2026-01-28 | 2,825 | $41.02 | $115,881.5 |
| 2025-12-09 | 32 | $39.96 | $1,278.72 |
| 2025-11-28 | 87 | $41.18 | $3,582.66 |
| 2025-11-26 | 87 | $41.18 | $3,582.66 |
| 2025-11-25 | 87 | $40.83 | $3,552.21 |
| 2025-11-24 | 7 | $40.45 | $283.15 |
| 2025-11-21 | 7 | $39.77 | $278.39 |
| 2025-11-20 | 7 | $39.67 | $277.69 |
| 2025-11-06 | 42 | $40.33 | $1,693.86 |
| 2025-11-03 | 447 | $40.02 | $17,888.94 |
| 2025-10-31 | 23 | $39.91 | $917.93 |
| 2025-10-15 | 64 | $40.07 | $2,564.48 |
Source: SEC Regulation SHO FTD data. Data is reported with a ~30 day delay. High FTD quantities relative to average daily volume may indicate settlement stress.
Compare CNO to Peers
Quant metrics computed deterministically from financial statements and price data. Updated: N/A.
SecuritiesDB provides programmatic data aggregation for informational purposes only. None of the metrics, summaries, or algorithmic flags constitute a recommendation to buy or sell any security.